Virginia DeJesus-Rueff

Virginia DeJesus-Rueff's Title

Virginia DeJesus-Rueff holds the prestigious dual role of Chief of Staff and Head of Strategy. In these capacities, she oversees strategic initiatives and ensures the seamless execution of company-wide projects. Her extensive background in consulting and life sciences equips her with the expertise to drive organizational growth and innovation, making her a pivotal leader in her field.

Virginia DeJesus-Rueff's Education and Expertise

Virginia DeJesus-Rueff has a robust academic foundation with an A.B. in Economics from Dartmouth College. She further honed her business acumen by earning an M.B.A. from Stanford Graduate School of Business, where she was distinguished as both an Arjay Miller Scholar and a Siebel Scholar. These accolades reflect her academic excellence and leadership potential, underpinning her strategic thinking and analytical prowess.

Virginia DeJesus-Rueff's Background

Virginia DeJesus-Rueff's career trajectory includes significant roles in both the private and public sectors. She started as a Research Associate at the Federal Reserve Bank of Boston, where she gained valuable insights into economic policy and financial systems. She then transitioned to McKinsey & Co. as an Associate, where she developed her strategic consulting skills by working on diverse projects across various industries.

Virginia DeJesus-Rueff's Experience at Genentech

From 2007 to 2018, Virginia DeJesus-Rueff made substantial contributions at Genentech in various capacities. She served as a Disease Area Director and LifeCycle Leader, roles in which she was responsible for guiding product development and lifecycle management. Her work significantly impacted the company's strategic direction, particularly in the areas of oncology and immunology, showcasing her ability to lead complex projects in a highly regulated industry.

Virginia DeJesus-Rueff's Achievements

Virginia DeJesus-Rueff's career is marked by notable achievements, including her recognition as an Arjay Miller Scholar and a Siebel Scholar at Stanford. At Genentech, she played a key role in the development and lifecycle management of critical therapeutic areas, contributing to the company's success in delivering innovative healthcare solutions. Her strategic insights and leadership have consistently driven organizational success and growth.